SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-033991
Filing Date
2021-06-23
Accepted
2021-06-23 16:01:02
Documents
2
Period of Report
2021-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_AGM itrm-8k_20210623.htm 8-K 54312
2 EX-99.1 itrm-ex991_6.htm EX-99.1 161497
  Complete submission text file 0001564590-21-033991.txt   217243
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 211038723
SIC: 2834 Pharmaceutical Preparations